Form 4: Alkami Technology CFO W. Bryan Hill Executes Stock Option and Sells Shares
SEC Form 4 Filing
W. Bryan Hill, CFO of Alkami Technology, exercised stock options and sold shares of common stock on August 26 and 27, 2024.
Summary
- On August 26 and 27, 2024, W. Bryan Hill, the Chief Financial Officer of Alkami Technology, Inc., engaged in transactions involving the company's stock.
- Hill exercised stock options to acquire 30,489 shares on August 26 and 69,511 shares on August 27 at an exercise price of $2.34 per share.
- Concurrently, Hill sold 30,489 shares on August 26 at a weighted average price of $33.7532 and 69,511 shares on August 27 at a weighted average price of $33.3364.
- Following these transactions, Hill directly owns 489,340 shares of Alkami Technology, Inc.
- The exercised options were fully vested and exercisable as of the transaction dates, with an expiration date of April 1, 2029.
- After the transactions, Hill continues to hold options to purchase 400,000 shares of Alkami Technology common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports transactions. The CFO exercising options and selling shares is a common practice, and the filing itself doesn't indicate any positive or negative outlook.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings to gauge management's sentiment about the company's prospects.
Comparison to Industry Standards
- Insider trading activity is a common occurrence in publicly listed companies.
- Comparing the CFO's transactions to those of executives at similar fintech companies like Blend Labs or nCino could provide context on whether these actions are typical or unusual.
- Analyzing the volume of shares sold relative to the CFO's total holdings and the company's overall market capitalization can help determine the significance of these transactions.
Stakeholder Impact
- The transactions could have a minor impact on shareholders, potentially creating slight downward pressure on the stock price due to the sale of shares.
- The impact on employees, customers, suppliers, and creditors is likely to be negligible.
Key Dates
| Date | Description |
|---|---|
| 08/26/2024 | CFO exercised stock options for 30,489 shares and sold 30,489 shares. |
| 08/27/2024 | CFO exercised stock options for 69,511 shares and sold 69,511 shares. |
| 08/28/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.